Home › Companies › CLOVER HEALTH INVESTMENTS CORP. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CLOVER HEALTH INVESTMENTS CORP.’s Form 8-K, filed June 13, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 10, 2024: 5 items on CLOVER HEALTH INVESTMENTS CORP.’s Form 8-K, filed June 13, 2024: 3 elected · 1 approved · 1 passed (calculated).
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore CLOVER HEALTH INVESTMENTS CORP. in the interactive database Compare manager voting policies
These tallies are CLOVER HEALTH INVESTMENTS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Chelsea Clinton | 937,120,902 | -- | -- | 26,227,596 | 145,211,573 | 97% | Elected | — |
| Elect Director: Carladenise Armbrister Edwards | 942,172,343 | -- | -- | 21,176,155 | 145,211,573 | 98% | Elected | — |
| Elect Director: Vivek Garipalli | 941,392,586 | -- | -- | 21,955,912 | 145,211,573 | 98% | Elected | — |
| 2. Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2023 | 950,591,272 | 10,963,460 | 1,793,766 | -- | 145,211,573 | 99% | Passed (calculated) | — |
| 3. Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024 | 1,100,958,512 | 5,333,701 | 2,267,858 | -- | -- | 99.5% | Approved | — |
Source: CLOVER HEALTH INVESTMENTS CORP., Form 8-K, filed with the SEC on June 13, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
96 asset managers disclosed a vote on at least one CLOVER HEALTH INVESTMENTS CORP. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Carladenise Armbrister Edwards
CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Elect Director: Carladenise Armbrister Edwards”): 942,172,343 for, 21,176,155 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Chelsea Clinton, Carladenise Armbrister Edwards and Vivek Garipalli were each elected to the Company's Board of Directors as Class III directors, to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 11 asset managers below reported 8,172,373 for, 182,197 withheld, 6,044 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,392,317 | 0 | 0 | 0 | For |
| Charles Schwab | 3,100,280 | 0 | 0 | 0 | For |
| Invesco | 403,162 | 0 | 0 | 0 | For |
| Fidelity | 265,255 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 163,124 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 16,600 | Withhold |
| BlackRock | 9,673 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 6,044 | 0 | Abstain |
| Nationwide | 0 | 0 | 0 | 1,916 | Withhold |
| State Street | 1,686 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 557 | Withhold |
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Chelsea Clinton
CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Elect Director: Chelsea Clinton”): 937,120,902 for, 26,227,596 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Chelsea Clinton, Carladenise Armbrister Edwards and Vivek Garipalli were each elected to the Company's Board of Directors as Class III directors, to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 11 asset managers below reported 4,588,936 for, 3,765,634 withheld, 6,044 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,392,317 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 3,100,280 | Withhold |
| Invesco | 0 | 0 | 0 | 403,162 | Withhold |
| Fidelity | 185,260 | 0 | 0 | 79,995 | Mixed |
| Voya | 0 | 0 | 0 | 163,124 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 16,600 | Withhold |
| BlackRock | 9,673 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 6,044 | 0 | Abstain |
| Nationwide | 0 | 0 | 0 | 1,916 | Withhold |
| State Street | 1,686 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 557 | Withhold |
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Vivek Garipalli
CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Elect Director: Vivek Garipalli”): 941,392,586 for, 21,955,912 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Chelsea Clinton, Carladenise Armbrister Edwards and Vivek Garipalli were each elected to the Company's Board of Directors as Class III directors, to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 11 asset managers below reported 8,170,687 for, 183,883 withheld, 6,044 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,392,317 | 0 | 0 | 0 | For |
| Charles Schwab | 3,100,280 | 0 | 0 | 0 | For |
| Invesco | 403,162 | 0 | 0 | 0 | For |
| Fidelity | 265,255 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 163,124 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 16,600 | Withhold |
| BlackRock | 9,673 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 6,044 | 0 | Abstain |
| Nationwide | 0 | 0 | 0 | 1,916 | Withhold |
| State Street | 0 | 0 | 0 | 1,686 | Withhold |
| Victory Capital | 0 | 0 | 0 | 557 | Withhold |
Combines 9 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 98.4% for (June 7, 2023 meeting) ▲ 0.5 pts
Description as filed by funds: NON-BINDING ADVISORY PROPOSAL TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS FOR 2023.
CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“2. Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2023”): 950,591,272 for, 10,963,460 against, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,392,317 | 0 | 0 | 0 | For |
| Charles Schwab | 3,100,280 | 0 | 0 | 0 | For |
| Invesco | 403,162 | 0 | 0 | 0 | For |
| Fidelity | 265,255 | 0 | 0 | 0 | For |
| Voya | 163,124 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 16,600 | 0 | 0 | 0 | For |
| BlackRock | 9,673 | 0 | 0 | 0 | For |
| John Hancock | 6,044 | 0 | 0 | 0 | For |
| Nationwide | 1,916 | 0 | 0 | 0 | For |
| State Street | 1,686 | 0 | 0 | 0 | For |
| Victory Capital | 557 | 0 | 0 | 0 | For |
Fund voting reports, all 11 managers: 8,360,614 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 6,127,805 | 0 | 0 | 0 | For |
| Renaissance | 5,411,890 | 0 | 0 | 0 | For |
| JUPITER ASSET MANAGEMENT LTD | 4,525,079 | 0 | 0 | 0 | For |
| Charles Schwab | 3,100,280 | 0 | 0 | 0 | For |
| DE Shaw | 1,838,140 | 0 | 0 | 0 | For |
| Two Sigma | 1,573,966 | 0 | 0 | 0 | For |
| Allianz | 0 | 786,333 | 0 | 0 | Against |
| GMT CAPITAL CORP | 0 | 701,600 | 0 | 0 | Against |
| Connor, Clark & Lunn Investment Management Ltd. | 540,663 | 0 | 0 | 0 | For |
| State Street | 518,564 | 0 | 0 | 0 | For |
| Northern Trust | 443,118 | 0 | 0 | 0 | For |
| Invesco | 414,436 | 0 | 0 | 0 | For |
| UBS | 0 | 274,212 | 0 | 0 | Against |
| Vanguard | 243,131 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 165,279 | 0 | 0 | 0 | For |
| Voya | 163,124 | 0 | 0 | 0 | For |
| Point72 | 126,910 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 121,924 | 0 | 0 | 0 | For |
| Dimensional | 0 | 94,128 | 0 | 0 | Against |
| REGIONS FINANCIAL CORP | 91,500 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 89,624 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 85,061 | 0 | 0 | 0 | For |
| Aureus Asset Management, LLC | 0 | 79,000 | 0 | 0 | Against |
| AQR | 66,725 | 0 | 0 | 0 | For |
| Arizona State Retirement System | 0 | 64,919 | 0 | 0 | Against |
Institutional-manager reports, all 90 managers: 25,939,126 for, 2,086,374 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.5% Approved · of votes cast
Prior year: 99.7% for (June 7, 2023 meeting) ▼ 0.2 pts
Description as filed by funds: The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm.
CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“3. Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024”): 1,100,958,512 for, 5,333,701 against — passed, per its Form 8-K filed June 13, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 11 asset managers below reported 8,360,614 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,392,317 | 0 | 0 | 0 | For |
| Charles Schwab | 3,100,280 | 0 | 0 | 0 | For |
| Invesco | 403,162 | 0 | 0 | 0 | For |
| Fidelity | 265,255 | 0 | 0 | 0 | For |
| Voya | 163,124 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 16,600 | 0 | 0 | 0 | For |
| BlackRock | 9,673 | 0 | 0 | 0 | For |
| John Hancock | 6,044 | 0 | 0 | 0 | For |
| Nationwide | 1,916 | 0 | 0 | 0 | For |
| State Street | 1,686 | 0 | 0 | 0 | For |
| Victory Capital | 557 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 486,374,644 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 0.90% |
| 2 | Charles Schwab | 0.64% |
| 3 | Invesco | 0.08% |
| 4 | Fidelity | 0.05% |
| 5 | Voya | 0.03% |
| 6 | Blackstone Alternative Investment Funds | <0.01% |
| 7 | BlackRock | <0.01% |
| 8 | John Hancock | <0.01% |
| 9 | Nationwide | <0.01% |
| 10 | State Street | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 1.26% |
| 2 | Renaissance | 1.11% |
| 3 | JUPITER ASSET MANAGEMENT LTD | 0.93% |
| 4 | Charles Schwab | 0.64% |
| 5 | DE Shaw | 0.38% |
| 6 | Two Sigma | 0.32% |
| 7 | Allianz | 0.16% |
| 8 | GMT CAPITAL CORP | 0.14% |
| 9 | Connor, Clark & Lunn Investment Management Ltd. | 0.11% |
| 10 | State Street | 0.11% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Vivek Garipalli | 88,817,153 | 18.26% | Proxy statement (DEF 14A), table as of December 31, 2023 |
| Entities affiliated with Vivek Garipalli | 83,584,543 | 17.19% | Proxy statement (DEF 14A), table as of December 31, 2023 |
| BlackRock | 30,394,942 | 6.25% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 23,060,008 | 4.74% | Form 13F, quarter ended March 31, 2024 |
| Renaissance Technologies | 11,396,600 | 2.34% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 4,301,558 | 0.88% | Form 13F, quarter ended March 31, 2024 |
| D.E. Shaw | 3,718,177 | 0.76% | Form 13F, quarter ended March 31, 2024 |
| Charles Schwab | 3,094,125 | 0.64% | Form 13F, quarter ended March 31, 2024 |
| Andrew Toy | 2,689,623 | 0.55% | Proxy statement (DEF 14A), table as of December 31, 2023 |
| Two Sigma | 2,525,895 | 0.52% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 486,374,644 shares outstanding, as reported by CLOVER HEALTH INVESTMENTS CORP. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At CLOVER HEALTH INVESTMENTS CORP.'s shareholder meeting held June 10, 2024, in the 2023-2024 proxy season, 96 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 267 separate fund positions. On the most widely held item on that ballot — NON-BINDING ADVISORY PROPOSAL TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS… — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CLOVER HEALTH INVESTMENTS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CLOVER HEALTH INVESTMENTS CORP.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
CLOVER HEALTH INVESTMENTS CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “CLOVER HEALTH INVESTMENTS (CLOV) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/clover-health-investments-corp/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.